AstraZeneca PLC is 2.6x more valuable than VERTEX PHARMACEUTICALS INC / MA by market capitalization ($286.27 B vs $110.59 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VRTX | AZN |
|---|---|---|
| Market cap | $110.59 B | $286.27 B |
| US-listed rank | #134 | #45 |
| Revenue (latest FY) | $12.00B | - |
| Net income (latest FY) | $3.95B | - |
| Net margin | 32.9% | - |
| P/E (trailing FY) | 28.0 | - |
| SEC filings | 1,000 | 1,004 |
AstraZeneca PLC is 2.6x more valuable than VERTEX PHARMACEUTICALS INC / MA by market capitalization ($286.27 B vs $110.59 B).
Full pages: VERTEX PHARMACEUTICALS INC / MA and AstraZeneca PLC, or browse the full rankings.